| Literature DB >> 35232459 |
Peng Zhang1,2, Chunbao Li3, Wenliang Wang1, Baiqing Zhang2, Weicheng Miao1, Yujie Liu4.
Abstract
BACKGROUND: This meta-analysis aimed to evaluate the current evidence on the diagnostic performance of MRI/MRA for detecting acetabular labral tears (ALT).Entities:
Keywords: Arthrography; Diagnosis; Hip injuries; Magnetic resonance imaging; Meta-analysis
Mesh:
Year: 2022 PMID: 35232459 PMCID: PMC8886969 DOI: 10.1186/s13018-022-02981-1
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Selection process for studies included in the meta-analysis
Characteristics of the included studies
| Study | Country/Year | Study design | Subjects/hips | Mean age | Sex (F:M) | MR type | Mean time MR to surgery | Reference standard | Reference test blinded design | Index test blinded design | MR reviewers | Radiologists reliability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Freedman BA | USA/2006 | ① | 24/24 | 37.1 | 13:11 | MRA(1.5 T) | > 6 months | Arthroscopy | NA | Yes | 1 MSK Radiologist | |
| Leunig M | Switzerland/1997 | ① | 23/23 | 40 | 14:9 | MRA(1.5 T) | 5 months | Arthroscopy | NA | NA | NA | NA |
| Toomayan GA | USA/2006 | ① | 48/51 | 35 | 27:21 | MRI(1.5 T) MRA(1.5 T) | NA | Arthroscopy | NA | Yes | 6 MSK radiologists | NA |
| Chan YS | China/2005 | ② | 30/17 | 41 | 13:17 | MRA(1.5 T) | NA | Arthroscopy | NA | Yes | 3 MSK Radiologists | NA |
| Byrd JW | USA/2004 | ① | 40/40 | NA | NA | MRI(1.5 T) MRA(1.5 T) | NA | Arthroscopy | NA | NA | 1 of 2 MSK Radiologists | NA |
| Mintz DN | USA/2005 | ① | 92/92 | 38.5 | 58:34 | MRI(1.5 T) | NA | Arthroscopy | NA | Yes | 2 MSK Radiologists | 92% agreement |
| Studler U | Switzerland/2008 | ① | 57/57 | 35 | 36:21 | MRI(1.5 T) MRA(1.5 T) | NA | Open surgery and arthroscopy | NA | Yes | 2 MSK Radiologists | |
| Petersilge CA | USA/1996 | ① | 10/10 | 38.4 | 5:5 | MRA(1.5 T) | NA | Open surgery and arthroscopy | No | NA | 1 MSK Radiologist | NA |
| Keeney JA | USA/2004 | ① | 101/102 | 37.6 | 70:31 | MRA(1.5 T) | NA | arthroscopy | No | NA | subspecialty radiologists | NA |
| Aprato A | Italy/2013 | ③ | 41/41 | 24.0 | 17:24 | MRA(1.5 T,apply traction) | < 6 months | Open surgery and arthroscopy | NA | NA | Subspecialty MSK radiologists | NA |
| Banks DB | UK/2012 | ① | 66/69 | NA | NA | MRA(1.5 T) | < 12 weeks | Arthroscopy | No | Yes | MSK radiologist | NA |
| Magee T | USA/2015 | ① | 43/43 | 34 | 15:28 | MRI(3.0 T)MRA(3.0 T) | 18 days | Arthroscopy | No | Yes | 2 MSK radiologists | MRI: MRA: |
| Tian CY | China/2014 | ① | 90/90 | 35.1 | 46:44 | MRI(3.0 T)MRA(3.0 T) | 49.7 days | Arthroscopy | No | Yes | 2 radiologists | MRI: MRA: |
| Reurink G | Netherlands/2012 | ① | 93/95 | 40.1 | 64:31 | MRA(1.5 T) | 153 day | Arthroscopy | NA | Yes | 2 MSK radiologists | |
| Crespo-Rodríguez AM | Spain/2017 | ① | 50/50 | 42.5 | 20:30 | MRA(1.5 T,apply traction) MRI(3.0 T) | 8 months | Arthroscopy | No | Yes | NA | NA |
| Carulli C | Italy/2018 | ① | 24/29 | 38.3 | 6:18 | MRA(1.5 T) | NA | Arthroscopy | Yes | Yes | NA | NA |
| Annabell L | Australia/2018 | ① | 68/71 | NA | 30:41 | MRI(3.0 T) | < 6 months | arthroscopy | NA | Yes | 2 MSK radiologists | |
| Saied AM | Belgium/2019 | ① | 482/490 | 39.5 | 262: 228 | MRI(1.5 T) MRA(1.5 T) | NA | Arthroscopy | No | NA | 1 MSK radiologist | NA |
| Linda DD | Canada/2017 | ① | 38/42 | 29 | 13:25 | MRI(3.0 T) | 154 days | Arthroscopy | No | Yes | 2 MSK radiologists | NA |
| Sutter R | Switzerland/2014 | ② | 28/28 | 31.8 | 10:18 | MRI(1.5 T) MRA(1.5 T) | 4 months | Open surgery and arthroscopy | NA | Yes | 2 MSK radiologists | MRI: |
| Sahin M | Turkey/2014 | ① | 14/14 | 35 | 11:3 | MRA(1.5 T) | NA | Arthroscopy | NA | Yes | 2 MSK radiologists | NA |
| Schmaranzer F | Austria/2015 | ① | 73/75 | 34.5 | 28:45 | MRA(1.5 T)(apply traction) | NA | Arthroscopy | NA | Yes | 2 MSK radiologists |
MR, magnetic resonance; MRA, magnetic resonance arthrogram; MRI, magnetic resonance imaging; MSK musculoskeletal; ① Retrospective study; ② Prospective study; ③ Unclear; a: intraobserver reliability; b: interobserver reliability; NA not available
Fig. 2Risk of bias and applicability concerns summary (A). Risk of bias and applicability concerns graph (B)
QUADAS-2 evaluation
| Study | QUADAS Score* | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | Bias | Appl | 4 | 5 | Bias | Appl | 6 | 7 | Bias | Appl | 8 | 9 | 10 | Bias | |
| Freedman BA | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | 1 | 1 | 1 | Low |
| Leunig M | NC | 1 | 1 | Low | Low | NC | 1 | Low | Low | 1 | NC | Low | Low | 1 | 1 | 1 | Low |
| Toomayan GA | 0 | 1 | 1 | High | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | NC | 1 | 1 | Low |
| Chan YS | 0 | 1 | 1 | High | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | NC | 1 | 0 | High |
| Byrd JW | NC | 1 | 1 | Low | Low | NC | 1 | Low | Low | 1 | NC | Low | Low | NC | 1 | 1 | Low |
| Mintz DN | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | NC | 1 | 1 | Low |
| Studler U | 1 | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | NC | Low | High | NC | 0 | 1 | High |
| Petersilge CA | NC | 1 | 1 | Low | Low | NC | 1 | Low | Low | 1 | 0 | High | High | NC | 0 | 1 | High |
| Keeney JA | 1 | 1 | 1 | Low | Low | NC | 1 | Low | Low | 1 | 0 | High | Low | NC | 1 | 1 | Low |
| Aprato A | NC | 1 | 1 | Low | Low | NC | 1 | Low | Low | 1 | NC | Low | High | 1 | 0 | 1 | High |
| Banks DB | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 0 | High | Low | 1 | 1 | 1 | Low |
| Magee T | 1 | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 0 | High | Low | 1 | 1 | 1 | Low |
| Tian CY | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 0 | High | Low | 1 | 1 | 1 | Low |
| Reurink G | 0 | 1 | 1 | High | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | 1 | 1 | 1 | Low |
| Crespo-Rodríguez AM | 1 | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 0 | High | Low | 1 | 1 | 1 | Low |
| Carulli C | 1 | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 1 | Low | Low | NC | 1 | 1 | Low |
| Annabell L | 1 | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | 1 | 1 | 1 | Low |
| Saied AM | NC | 1 | 1 | Low | Low | NC | 1 | Low | Low | 1 | 0 | High | Low | NC | 1 | 1 | Low |
| Linda DD | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 0 | High | Low | 1 | 1 | 1 | Low |
| Sutter R | 0 | 1 | 1 | High | Low | 1 | 1 | Low | Low | 1 | NC | Low | High | 1 | 0 | 1 | High |
| Sahin M | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | NC | 1 | 1 | Low |
| Schmaranzer F | 1 | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | NC | Low | Low | NC | 1 | 1 | Low |
| Lee GY | NC | 1 | 1 | Low | Low | 1 | 1 | Low | Low | 1 | 1 | Low | Low | NC | 1 | 1 | Low |
The numbers in the top row correspond to the following questions: Domain 1: Patient selection. Numbers correspond with the following questions: (1) Was a consecutive or random sample of patients enrolled? (2) Was a case–control design avoided? (3) Did the study avoid inappropriate exclusions? Domain 2: Index test. Numbers correspond with the following questions: (4) Were the index test results interpreted without knowledge of the results of the reference standard? (5) If a threshold was used, was it pre-specified? Domain 3: Reference test. Numbers correspond with the following questions: (6) Is the reference standard likely to correctly classify the target condition? (7) Were the reference standard results interpreted without knowledge of the results of the index test? Domain 4: Flow and timing. Numbers correspond with the following questions: (8) Was there an appropriate interval between index test(s) and reference standard? (9) Did all patients receive a reference standard? (10) Were all patients included in the analysis?
*Number 1 indicates “yes,” and 0 indicates “no”; Bias risk: of bias; Appl.: concerns regarding applicability; NC: not clear
Fig. 3Forest plots of sensitivity and specificity. MRI (A), MRA (B)
Fig. 4Summary receiver operating characteristic curve (SROC). MRI (A), MRA (B)
Fig. 5Fagan plots of pre-test and post-test probabilities. MRI (A), MRA (B)
Fig. 6Univariable meta-regression. MRI (A), MRA (B)
Subgroup analysis
| Subgroup | Se (95% CI) | Sp (95% CI) | LR+ (95% CI) | LR– (95% CI) | DOR (95% CI) | Number of studies |
|---|---|---|---|---|---|---|
1.5 T MRI | 0.69 (0.64–0.75) | 0.79 (0.67–0.87) | 1.64 (0.79–3.40) | 0.65 (0.37–1.15) | 3.18 (0.84–12.07) | 6 |
1.5 T MRA | 0.82 (0.79–0.84) | 0.59 (0.52–0.66) | 1.90 (1.39–2.58) | 0.26 (0.16–0.41) | 11.04 (4.75–25.63) | 16 |
3.0 T MRI | 0.87 (0.82–0.91) | 0.77 (0.64–0.87) | 2.40 (1.32–4.35) | 0.14 (0.04–0.49) | 20.47 (4.56–91.83) | 5 |
3.0 T MRA | NA | NA | NA | NA | NA | 2 |
| Reference-1 MRI | 0.77 (0.73–0.81) | 0.79 (0.70–0.85) | 2.07 (1.30–3.30) | 0.38 (0.22–0.66) | 7.79 (2.87–21.12) | 10 |
| Reference-1 MRA | 0.81 (0.78–0.84) | 0.59 (0.52–0.66) | 1.86 (1.33–2.59) | 0.30 (0.18–0.48) | 8.78 (3.67–21.04) | 14 |
Reference-2 MRI | 0.77 (0.62–0.92) | 0.50 (0.32–0.68) | NA | NA | NA | 1 |
Reference-2 MRA | 0.92 (0.85–0.96) | 0.67 (0.45–0.84) | 2.64 (1.20–5.84) | 0.14 (0.07–0.27) | 38.16 (9.84–148.0) | 4 |
Reference-1: Arthroscopy, Reference-2: Arthroscopy and open surgery, NA not available
Fig. 7The Deeks’ funnel plot. MRI (A), MRA (B)